摘要
为进一步促进药师规范化、同质化地开展动脉粥样硬化性心血管疾病(ASCVD)患者降胆固醇药物治疗管理,受中国医药教育协会委托,由首都医科大学附属北京安贞医院、北京大学第一医院、重庆医科大学附属第一医院、同济大学附属同济医院、河南中医学大学第五临床医学院(郑州人民医院)和中山大学附属第一医院共同牵头制定《动脉粥样硬化性心血管疾病患者降胆固醇药物治疗管理专家共识》。本共识紧密围绕ASCVD患者降胆固醇药物治疗管理的全过程,包括信息收集、分析评估、计划实施及后续跟踪随访,同时配套标准化管理路径、记录表单和评估工具,并重点针对降胆固醇方案评估(疗效评估、治疗药物选择评估、用法用量评估、不良反应评估、相互作用评估、经济性评估、依从性评估)形成7条评估建议,以期为临床工作提供参考。
To further promote the standardization and homogenization of pharmacists in the management of cholesterol lowering drug therapy in patients with atherosclerotic cardiovascular disease(ASCVD), Beijing Anzhen Hospital, Capital Medical University, Peking University First Hospital, the First Affiliated Hospital of Chongqing Medical University, Tongji Hospital of Tongji University, the Fifth Chinical Medical College of Henan University of Chinese Medicine(Zhengzhou People’s Hospital) and the First Affiliated Hospital, Sun Yat-sen University, commissioned by China Medicine Education Association, have jointly formulated the Expert Consensus on the Management of Cholesterol Lowering Drugs in Patients with Atherosclerotic Cardiovascular Diseases. The consensus closely focuses on the whole process of cholesterol lowering drug therapy management for ASCVD patients, including information collection, analysis and evaluation, plan implementation, and follow-up.The consensus also contains standardized management pathways, record forms and assessment tools, and 7 tips for the assessment of cholesterol lowering drug treatment regimens, including assessment of efficacy, therapeutic drug selection, dosage, adverse reactions, interactions, economy, and compliance, to provide reference for clinical practice.
作者
《动脉粥样硬化性心血管疾病患者降胆固醇药物治疗管理专家共识》编写组
林阳
Compilation Group of Expert Consensus on the Management of Cholesterol Lowering Drugs in Patients with Atherosclerotic Cardiovascular Diseases
出处
《临床药物治疗杂志》
2023年第2期7-16,共10页
Clinical Medication Journal
关键词
共识
动脉粥样硬化性心血管疾病
胆固醇
药物治疗管理
consensus
atherosclerotic cardiovascular disease
cholesterol
medication therapy management
